|
CN1030415A
(zh)
|
1987-02-20 |
1989-01-18 |
山之内制药株式会社 |
饱和的杂环碳酰胺衍生物和它的制备方法
|
|
ES2005163A6
(es)
|
1987-04-14 |
1989-03-01 |
Lilly S A E |
Un procedimiento para la produccion de derivados de tiofen-2-carboxamida.
|
|
PT90001B
(pt)
|
1988-03-16 |
1994-06-30 |
Zambeletti Spa L |
Processo para a preparacao de derivados heterociclicos de etilenodiamina
|
|
DE3810848A1
(de)
|
1988-03-30 |
1989-10-19 |
Boehringer Ingelheim Kg |
Neue 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole, ihre herstellung und verwendung
|
|
DE3927483A1
(de)
|
1989-08-19 |
1991-02-21 |
Boehringer Ingelheim Kg |
Neue substituierte heterocyclische fuenfringe, ihre herstellung und verwendung
|
|
DE3933573A1
(de)
|
1989-10-07 |
1991-04-18 |
Basf Ag |
Carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
|
|
US5258357A
(en)
*
|
1989-10-07 |
1993-11-02 |
Basf Aktiengesellschaft |
Carboxamides, their preparation and their use as herbicides
|
|
US6645969B1
(en)
|
1991-05-10 |
2003-11-11 |
Aventis Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
US5559235A
(en)
|
1991-10-29 |
1996-09-24 |
Glaxo Wellcome Inc. |
Water soluble camptothecin derivatives
|
|
GB9201755D0
(en)
|
1992-01-28 |
1992-03-11 |
British Bio Technology |
Compounds
|
|
US5595872A
(en)
|
1992-03-06 |
1997-01-21 |
Bristol-Myers Squibb Company |
Nucleic acids encoding microsomal trigyceride transfer protein
|
|
US5342947A
(en)
|
1992-10-09 |
1994-08-30 |
Glaxo Inc. |
Preparation of water soluble camptothecin derivatives
|
|
JP3322878B2
(ja)
|
1992-10-14 |
2002-09-09 |
メルク エンド カンパニー インコーポレーテッド |
フィブリノーゲンレセプターアンタゴニスト
|
|
JPH08502508A
(ja)
*
|
1992-10-23 |
1996-03-19 |
メルク シヤープ エンド ドーム リミテツド |
ドーパミンレセプターサブタイプリガンド
|
|
FR2707295A1
(fr)
|
1993-06-07 |
1995-01-13 |
Rhone Poulenc Agrochimie |
Fongicides pyrazoles substitués en position 3 par un hétérocycle.
|
|
DE69418045T2
(de)
*
|
1993-08-06 |
1999-10-07 |
Smithkline Beecham P.L.C., Brentford |
Amidderivate als 5ht1d rezeptor antagonisten
|
|
US5739135A
(en)
*
|
1993-09-03 |
1998-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
|
US5681835A
(en)
|
1994-04-25 |
1997-10-28 |
Glaxo Wellcome Inc. |
Non-steroidal ligands for the estrogen receptor
|
|
US5491237A
(en)
|
1994-05-03 |
1996-02-13 |
Glaxo Wellcome Inc. |
Intermediates in pharmaceutical camptothecin preparation
|
|
US5668148A
(en)
*
|
1995-04-20 |
1997-09-16 |
Merck & Co., Inc. |
Alpha1a adrenergic receptor antagonists
|
|
JP3964478B2
(ja)
*
|
1995-06-30 |
2007-08-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
|
|
US5846990A
(en)
*
|
1995-07-24 |
1998-12-08 |
Bristol-Myers Squibb Co. |
Substituted biphenyl isoxazole sulfonamides
|
|
CA2201477C
(en)
*
|
1995-08-02 |
2005-05-03 |
Javier Bartroli |
New pyrimidone derivatives with antifungal activity
|
|
BR9606546A
(pt)
*
|
1995-08-02 |
1998-07-14 |
Uriach & Cia Sa J |
Novas carboxamidas com atividade fungicida
|
|
CA2502764A1
(en)
|
1995-08-22 |
1997-03-06 |
Japan Tobacco Inc. |
Amide compounds
|
|
US6001866A
(en)
*
|
1995-10-05 |
1999-12-14 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
US5972980A
(en)
*
|
1995-10-05 |
1999-10-26 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
WO1997012613A1
(en)
*
|
1995-10-05 |
1997-04-10 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
US5942544A
(en)
*
|
1996-02-22 |
1999-08-24 |
Dupont Pharmaceuticals Company |
α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors
|
|
JP2000509371A
(ja)
|
1996-04-03 |
2000-07-25 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
|
JP2000507593A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
|
JP2000507592A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
|
AU716123B2
(en)
|
1996-04-03 |
2000-02-17 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
EP0904076A1
(en)
|
1996-04-03 |
1999-03-31 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
CA2249650A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
JP2000507595A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシルプロテイントランスフェラーゼの阻害剤
|
|
EP0891361A1
(en)
|
1996-04-03 |
1999-01-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036890A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AUPO163896A0
(en)
*
|
1996-08-14 |
1996-09-05 |
Resmed Limited |
Determination of respiratory airflow
|
|
WO1998037068A1
(en)
*
|
1997-02-21 |
1998-08-27 |
Bristol-Myers Squibb Company |
Benzoic acid derivatives and related compounds as antiarrhythmic agents
|
|
US5998336A
(en)
|
1997-02-26 |
1999-12-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ceramic/metal and A15/metal superconducting composite materials exploiting the superconducting proximity effect and method of making the same
|
|
WO1998054164A1
(en)
*
|
1997-05-30 |
1998-12-03 |
Takeda Chemical Industries, Ltd. |
Sulfonamide derivatives, their production and use
|
|
GB9716557D0
(en)
|
1997-08-06 |
1997-10-08 |
Glaxo Group Ltd |
Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
|
|
DE19744026A1
(de)
|
1997-10-06 |
1999-04-08 |
Hoechst Marion Roussel De Gmbh |
Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
|
|
AU751139B2
(en)
*
|
1997-10-13 |
2002-08-08 |
Astellas Pharma Inc. |
Amide derivative
|
|
US6040447A
(en)
|
1997-12-12 |
2000-03-21 |
Euro-Celtique S.A. |
Purine compounds having PDE IV inhibitory activity and methods of synthesis
|
|
US6232320B1
(en)
*
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
AUPP433398A0
(en)
|
1998-06-25 |
1998-07-16 |
Australian National University, The |
Compounds and processes
|
|
US6192967B1
(en)
*
|
1998-10-19 |
2001-02-27 |
Sunny En Liung Huang |
Collapsible auto shade
|
|
US6130333A
(en)
*
|
1998-11-27 |
2000-10-10 |
Monsanto Company |
Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use
|
|
GB9827882D0
(en)
|
1998-12-17 |
1999-02-10 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE19904397A1
(de)
|
1999-02-04 |
2000-08-10 |
Bayer Ag |
Verwendung von Pyrazol-Carbonsäureamiden
|
|
DE19904396A1
(de)
|
1999-02-04 |
2000-08-10 |
Bayer Ag |
Substituierte Pyrazolbenzylamin-Derivate
|
|
JP2000256358A
(ja)
|
1999-03-10 |
2000-09-19 |
Yamanouchi Pharmaceut Co Ltd |
ピラゾール誘導体
|
|
HUP0203338A2
(hu)
|
1999-04-13 |
2003-03-28 |
Abbott Gmbh & Co. Kg |
Integrin receptor ligandumok
|
|
JP2003500382A
(ja)
|
1999-05-24 |
2003-01-07 |
シーオーアール セラピューティクス インコーポレイテッド |
Ｘａ因子の阻害剤
|
|
AU5283800A
(en)
*
|
1999-05-24 |
2000-12-12 |
Cor Therapeutics, Inc. |
Inhibitors of factor xa
|
|
JP2001247569A
(ja)
|
1999-08-12 |
2001-09-11 |
Japan Tobacco Inc |
ピロリジン誘導体又はピペリジン誘導体及びその医薬用途
|
|
US6632815B2
(en)
*
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
WO2001038309A1
(en)
|
1999-11-24 |
2001-05-31 |
Cor Therapeutics, Inc. |
β-AMINO ACID-, ASPARTIC ACID- AND DIAMINOPROPIONIC-BASED INHIBITORS OF FACTOR Xa
|
|
US6770666B2
(en)
*
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
|
EP1162196A4
(en)
|
1999-12-27 |
2003-04-16 |
Japan Tobacco Inc |
COMPOUNDS WITH JOINED CYCLES AND THEIR USE AS MEDICAMENTS
|
|
IL145757A
(en)
*
|
2000-02-05 |
2007-12-03 |
Vertex Pharma |
History of pyrazole and pharmaceutical preparations containing them
|
|
WO2001056557A2
(en)
|
2000-02-05 |
2001-08-09 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of erk
|
|
WO2001056993A2
(en)
|
2000-02-05 |
2001-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of erk
|
|
ES2254385T3
(es)
*
|
2000-02-29 |
2006-06-16 |
Millennium Pharmaceuticals, Inc. |
Benzamidas e inhibidores relacionados del factor xa.
|
|
GB0011098D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Pharmaceutical compositions comprising protpn pump inhibitors and gastrin/cholecystokinin receptor ligands
|
|
DE60112742T2
(de)
*
|
2000-05-19 |
2006-02-02 |
Applied Research Systems Ars Holding N.V. |
Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
|
|
US6589195B1
(en)
*
|
2000-05-26 |
2003-07-08 |
Orthomerica Products, Inc. |
Modular adjustable prophylactic hip orthosis and adduction/abduction joint
|
|
WO2002000647A1
(en)
*
|
2000-06-23 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Heteroaryl-phenyl substituted factor xa inhibitors
|
|
AU2001277143A1
(en)
|
2000-07-24 |
2002-02-05 |
Davide Riccardo Grassetti |
Inhibition of mutagenic effects of carcinogens
|
|
GB0018758D0
(en)
*
|
2000-07-31 |
2000-09-20 |
Smithkline Beecham Plc |
Novel use and compunds
|
|
JO2654B1
(en)
*
|
2000-09-04 |
2012-06-17 |
شركة جانسين فارماسوتيكا ان. في |
Multiple aryl caroxa amides are useful as lipid - lowering agents
|
|
DE60215139T2
(de)
*
|
2001-01-26 |
2007-08-16 |
Chugai Seiyaku K.K. |
Malonyl coa-decarboxylase inhibitoren als stoffwechselmodulatoren
|
|
CA2445568A1
(en)
*
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Triazole-derived kinase inhibitors and uses thereof
|
|
DE10223912A1
(de)
*
|
2001-06-28 |
2003-01-16 |
Merck Patent Gmbh |
TN- und STN-Flüssigkristallanzeigen
|
|
US20030015823A1
(en)
*
|
2001-07-18 |
2003-01-23 |
Hydranautics |
Method for forming a thick section, thermoset, solid casting
|
|
EP1423380B1
(en)
*
|
2001-08-03 |
2010-12-15 |
Vertex Pharmaceuticals Incorporated |
Pyrazole-derived kinase inhibitors and uses thereof
|
|
JP4357295B2
(ja)
*
|
2001-08-03 |
2009-11-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ピラゾール誘導キナーゼインヒビターとその使用
|
|
WO2003018585A1
(en)
*
|
2001-08-24 |
2003-03-06 |
Pharmacia & Upjohn Company |
Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
|
|
IL161047A0
(en)
*
|
2001-09-27 |
2004-08-31 |
Applied Research Systems |
Pyrazole derivatives for increasing endogenous testosterone levels
|
|
US6794252B2
(en)
*
|
2001-09-28 |
2004-09-21 |
Texas Instruments Incorporated |
Method and system for forming dual work function gate electrodes in a semiconductor device
|
|
WO2003035619A1
(en)
|
2001-10-25 |
2003-05-01 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6897208B2
(en)
*
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
|
WO2003039529A1
(en)
|
2001-11-07 |
2003-05-15 |
4Sc A.G. |
Selective antibacterial agents
|
|
TW200306819A
(en)
*
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
RU2004126671A
(ru)
|
2002-02-06 |
2005-04-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Гетероарилсоединения, полезные в качестве ингибиторов gsk-3
|
|
US7335779B2
(en)
|
2002-03-08 |
2008-02-26 |
Quonova, Llc |
Modulation of pathogenicity
|
|
GB0206860D0
(en)
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
|
GB0206861D0
(en)
*
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Medicaments
|
|
AU2003226149A1
(en)
|
2002-04-05 |
2003-10-27 |
Merck & Co., Inc. |
Substituted aryl amides
|
|
MXPA04010550A
(es)
*
|
2002-04-26 |
2005-01-25 |
Pfizer Prod Inc |
Inhibidores de metaloproteinasa de pirimidina-2,4,6-triona.
|
|
US7470543B2
(en)
*
|
2002-06-05 |
2008-12-30 |
Nerviano Medical Sciences S.R.L. |
Methods for identifying ligands using competitive binding 1H NMR experiments
|
|
GB0216224D0
(en)
*
|
2002-07-12 |
2002-08-21 |
Glaxo Group Ltd |
Compounds
|
|
JP2005539001A
(ja)
*
|
2002-08-02 |
2005-12-22 |
アージェンタ・ディスカバリー・リミテッド |
ヒストンデアセチラーゼインヒビターとしての置換チエニルヒドロキサム酸
|
|
TW200424183A
(en)
*
|
2002-08-09 |
2004-11-16 |
Nps Pharma Inc |
New compounds
|
|
US6649638B1
(en)
|
2002-08-14 |
2003-11-18 |
Ppd Discovery, Inc. |
Prenylation inhibitors and methods of their synthesis and use
|
|
AU2003265395A1
(en)
*
|
2002-08-14 |
2004-03-03 |
Ppd Discovery, Inc. |
Prenylation inhibitors and methods of their synthesis and use
|
|
JP2006501243A
(ja)
*
|
2002-08-23 |
2006-01-12 |
カイロン コーポレイション |
グリコーゲンシンターゼキナーゼ３のピロールベースのインヒビター
|
|
DE10239443A1
(de)
|
2002-08-28 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Blockiervorrichtung für ein Sperrspannwerk mit federbetätigtem Abtrieb
|
|
EP1398029A1
(en)
*
|
2002-09-10 |
2004-03-17 |
LION Bioscience AG |
NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives
|
|
US20060084682A1
(en)
|
2002-12-13 |
2006-04-20 |
Heerding Dirk A |
Thrombopoietin mimetics
|
|
AU2003297431A1
(en)
*
|
2002-12-20 |
2004-07-22 |
Pharmacia Corporation |
Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
|
|
EP1594846A1
(en)
*
|
2003-02-10 |
2005-11-16 |
Bayer HealthCare AG |
Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
|
|
US7601868B2
(en)
*
|
2003-02-12 |
2009-10-13 |
Takeda Pharmaceutical Company Limited |
Amine derivative
|
|
US7223788B2
(en)
*
|
2003-02-14 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
|
|
EP1599447A1
(en)
*
|
2003-02-28 |
2005-11-30 |
Galderma Research & Development, S.N.C. |
Ligands that modulate lxr-type receptors
|
|
US7517887B2
(en)
*
|
2003-04-09 |
2009-04-14 |
General Atomics |
Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
|
|
MXPA05011150A
(es)
*
|
2003-04-21 |
2005-12-14 |
Elan Pharm Inc |
2-hidroxi-3-diaminoalcanos de benzamida.
|
|
WO2004103968A1
(en)
*
|
2003-05-26 |
2004-12-02 |
Aponetics Ag |
Sulfopyrroles
|
|
JP4638423B2
(ja)
*
|
2003-06-20 |
2011-02-23 |
ガルデルマ・リサーチ・アンド・デヴェロップメント |
ＰＰＡＲγタイプ受容体を調節する新規化合物および化粧品組成物または医薬品組成物へのその使用
|
|
DE10331305A1
(de)
|
2003-07-10 |
2005-02-17 |
Siemens Ag |
Kommunikationssystem, Peer-to-Peer-Nachrichten-Filter-Rechner und Verfahren zum Verarbeiten einer Peer-to-Peer-Nachricht
|
|
FR2857666B1
(fr)
|
2003-07-15 |
2005-08-26 |
Oreal |
Composition tinctoriale comprenant a titre de coupleur un derive du furane et nouveaux derives du furane
|
|
EP1653968A4
(en)
|
2003-07-23 |
2006-09-06 |
Synta Pharmaceuticals Corp |
METHOD FOR MODULATING CALCIUMION RELIEF ACTIVATED CALCIUMION CHANNELS
|
|
WO2005019200A2
(en)
|
2003-08-14 |
2005-03-03 |
Icos Corporation |
Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
|
|
WO2005016920A1
(en)
|
2003-08-15 |
2005-02-24 |
Vertex Pharmaceuticals Incorporated |
Pyrrole compositions useful as inhibitors of c-met
|
|
WO2005019182A1
(en)
|
2003-08-20 |
2005-03-03 |
Bayer Healthcare Ag |
Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
|
|
WO2005037198A2
(en)
*
|
2003-10-06 |
2005-04-28 |
Glaxo Group Limited |
Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
|
|
WO2005034866A2
(en)
|
2003-10-06 |
2005-04-21 |
Glaxo Group Limited |
Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors
|
|
US20050267182A1
(en)
*
|
2003-11-13 |
2005-12-01 |
Ambit Biosciences Corporation |
Urea derivatives as FLT-3 modulators
|
|
US20050130954A1
(en)
|
2003-11-21 |
2005-06-16 |
Mitchell Ian S. |
AKT protein kinase inhibitors
|
|
US8652089B2
(en)
|
2004-01-19 |
2014-02-18 |
Arthrex, Inc. |
System for distending body tissue cavities by continuous flow irrigation
|
|
WO2005074642A2
(en)
|
2004-01-30 |
2005-08-18 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
AR047894A1
(es)
|
2004-02-25 |
2006-03-01 |
Wyeth Corp |
Derivados de tiofeno como inhibidores de la proteina tirosina fosfatasa 1b (ptpasa 1b); metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por ptpasa 1b
|
|
CN1989131A
(zh)
*
|
2004-03-30 |
2007-06-27 |
希龙公司 |
取代的噻吩衍生物用作抗癌药
|
|
WO2005099200A1
(en)
*
|
2004-03-30 |
2005-10-20 |
Matsushita Electric Industrial Co., Ltd. |
Content relay server, content relay system, content relay method, and program using the same
|
|
US7973061B2
(en)
|
2004-03-31 |
2011-07-05 |
Exelixis, Inc. |
Anaplastic lymphoma kinase modulators and methods of use
|
|
JP2005336172A
(ja)
|
2004-04-26 |
2005-12-08 |
Japan Tobacco Inc |
腎虚血再灌流障害治療又は予防薬
|
|
TW200600492A
(en)
*
|
2004-05-18 |
2006-01-01 |
Achillion Pharmaceuticals Inc |
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
|
|
AU2005247610A1
(en)
*
|
2004-05-29 |
2005-12-08 |
7Tm Pharma A/S |
Substituted thiazoleacetic as crth2 ligands
|
|
EP1765332A2
(en)
*
|
2004-06-17 |
2007-03-28 |
Cengent Therapeutics, Inc. |
Trisubstituted nitrogen modulators of tyrosine phosphatases
|
|
WO2006004984A1
(en)
*
|
2004-06-30 |
2006-01-12 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of protein kinases
|
|
US7671077B2
(en)
*
|
2004-07-19 |
2010-03-02 |
Leu-Fen Hou Lin |
Neuroprotective small organic molecules, compositions and uses related thereto
|
|
US20060019967A1
(en)
*
|
2004-07-21 |
2006-01-26 |
Su-Ying Wu |
SARS CoV main protease inhibitors
|
|
US20060019968A1
(en)
*
|
2004-07-24 |
2006-01-26 |
Laboratorios Dr. Esteve S.A. |
Use of compounds active on the sigma receptor for the treatment of neuropathic pain
|
|
US7269099B2
(en)
|
2004-07-30 |
2007-09-11 |
Bolt Technology Corporation |
Air gun
|
|
JP2006066488A
(ja)
*
|
2004-08-25 |
2006-03-09 |
Mitsubishi Electric Corp |
半導体受光素子およびその製造方法
|
|
US7365385B2
(en)
*
|
2004-08-30 |
2008-04-29 |
Micron Technology, Inc. |
DRAM layout with vertical FETs and method of formation
|
|
US20060043513A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Deok-Hoon Kim |
Method of making camera module in wafer level
|
|
TW200616969A
(en)
|
2004-09-17 |
2006-06-01 |
Tanabe Seiyaku Co |
Imidazole compound
|
|
US20060062453A1
(en)
*
|
2004-09-23 |
2006-03-23 |
Sharp Laboratories Of America, Inc. |
Color highlighting document image processing
|
|
WO2006043518A1
(ja)
|
2004-10-18 |
2006-04-27 |
Santen Pharmaceutical Co., Ltd. |
神経疾患治療剤
|
|
JP2006120339A
(ja)
|
2004-10-19 |
2006-05-11 |
Matsushita Electric Ind Co Ltd |
高周波加熱電源装置
|
|
TW200619843A
(en)
|
2004-10-20 |
2006-06-16 |
Sumitomo Bakelite Co |
Semiconductor wafer and semiconductor device
|
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
DE102004054666A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
CN101048383A
(zh)
*
|
2004-11-23 |
2007-10-03 |
惠氏公司 |
促性腺激素释放激素受体拮抗剂
|
|
WO2006058879A1
(en)
*
|
2004-11-30 |
2006-06-08 |
Neurosearch A/S |
Novel diazabicyclic aryl derivatives as cholinergy ligands
|
|
SE527990C2
(sv)
|
2004-12-06 |
2006-08-01 |
Mora Of Sweden Ab |
Isborr
|
|
CN101141957A
(zh)
|
2005-02-03 |
2008-03-12 |
Irm责任有限公司 |
作为ppar调节剂的化合物和组合物
|
|
JP2006232707A
(ja)
|
2005-02-23 |
2006-09-07 |
Japan Tobacco Inc |
癌転移抑制剤
|
|
EP1874952A2
(en)
|
2005-04-11 |
2008-01-09 |
Achillion Pharmaceuticals, Inc. |
Pharmaceutical compositions for and methods of inhibiting hcv replication
|
|
AR056319A1
(es)
*
|
2005-04-22 |
2007-10-03 |
Kalypsys Inc |
Inhibidores de orto-terfinilo de p38 quinasa, composicion farmaceutica y compuestos intermedios
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
WO2006136829A2
(en)
|
2005-06-21 |
2006-12-28 |
Astex Therapeutics Limited |
Pyrazole derivatives and their use as pka and pkb modulators
|
|
US20060288588A1
(en)
|
2005-06-22 |
2006-12-28 |
Frank Morabito |
Garden tool
|
|
EP1933832A2
(en)
*
|
2005-06-23 |
2008-06-25 |
Astex Therapeutics Limited |
Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
|
|
MA28394B1
(fr)
|
2005-06-24 |
2007-01-02 |
Genelabs Tech Inc |
Derives d'heteroaryle pour traitement des virus
|
|
WO2006136637A2
(es)
*
|
2005-06-24 |
2006-12-28 |
Eloy Antonio Martinez Albal |
Implante dental de corona rotatoria
|
|
WO2007002563A1
(en)
|
2005-06-27 |
2007-01-04 |
Exelixis, Inc. |
Imidazole based lxr modulators
|
|
CN100494167C
(zh)
|
2005-08-02 |
2009-06-03 |
天津大学 |
抗乙肝病毒的叔胺氧化物及制备方法和制备药物的应用
|
|
GB0518237D0
(en)
|
2005-09-07 |
2005-10-19 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
|
US7838676B2
(en)
*
|
2005-11-21 |
2010-11-23 |
Amgen Inc. |
Beta-secretase modulators and methods of use
|
|
AU2006325746A1
(en)
|
2005-12-14 |
2007-06-21 |
Bristol-Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
|
EP1968568A4
(en)
|
2005-12-22 |
2011-04-13 |
Glaxosmithkline Llc |
HEMMER OF NUTS ACTIVITY
|
|
ES2408318T3
(es)
|
2005-12-23 |
2013-06-20 |
Glaxosmithkline Llc |
Inhibidores de azaindol de las cinasas Aurora
|
|
AR056882A1
(es)
|
2006-02-01 |
2007-10-31 |
Bayer Cropscience Sa |
Derivados del fungicida n- cicloalquil- bencil- amida
|
|
JP5503874B2
(ja)
|
2006-02-28 |
2014-05-28 |
ダート ニューロサイエンス （ケイマン） エルティーディー |
治療化合物
|
|
JP2007277230A
(ja)
|
2006-03-15 |
2007-10-25 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
AU2007336781C1
(en)
|
2006-12-21 |
2014-10-09 |
Sloan-Kettering Institute For Cancer Research |
Pyridazinones and furan-containing compounds
|
|
WO2008079371A1
(en)
|
2006-12-22 |
2008-07-03 |
Encysive Pharmaceuticals, Inc. |
Modulators of c3a receptor and methods of use thereof
|
|
WO2008098105A1
(en)
|
2007-02-07 |
2008-08-14 |
Smithkline Beecham Corporation |
Inhibitors of akt activity
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
WO2008121685A1
(en)
|
2007-03-28 |
2008-10-09 |
Smithkline Beecham Corporation |
Methods of use for inhibitors of akt activity
|
|
US8338434B2
(en)
|
2007-03-29 |
2012-12-25 |
Glaxosmithkline Llc |
Inhibitors of Akt activity
|